Community
All
Created
Saved
Groups
Community
App Testing
Community

Welcome to our vibrant online community, where we encourage members to share their personal experiences and insights to foster collective growth and mutual support in our journey towards well-being.

Both Discussions Experiences
Create discussion
Create discussion
Acetylsalicylic acid
โค๏ธ - Liked
๐Ÿ˜Ž - Created by you
๐Ÿ•’ - Transferred within last month
Mention
IC or Complex
/
Posting
Wall post
Replies
c
cce wrote a comment to Magnesium 7 Plus
over 1 year ago
Ugggh! Why manganese? Toxin!
3 Likes
3 Comments
Mar 18, 2025
cce is needed, for example, for cartilage formation.
Show original
Liked
2
0 replies
Hide branch
Jun 09, 2024
cce, manganese citrate is not considered to be toxic in small amounts and especially as an IC;
"Manganese is an essential trace mineral necessary for various bodily functions, including bone formation, blood clotting, and the metabolism of amino acids, cholesterol, and carbohydrates."
Liked
3
1 reply
Hide branch
Load more comments...
Loading...
Wall post
Replies
Angelika Pfeifer
9 months ago
I would be grateful for recommendations for use in menopausal joint pain (including knees and fingers).
Show original
1 Likes
2 Comments
Mar 18, 2025
Author
Thanks Anton!
Show original
Liked
0
0 replies
Hide branch
Mar 18, 2025
Angelika Pfeifer, please see the following:
Joint Pain: This complex aims to reduce joint pain and support rehabilitation. It includes components like Glucosamine + Chondroitin (with MSM), Growth Hormone, Alendronate sodium, Traumeel, Arnica Montana 1M, and Oxycodone.ย 
Arthritis (inflammation of the joints): Designed to address joint inflammation, this complex comprises Acetylsalicylic acid, Dexamethasone, Diclofenac, Noni, and Ibuprofen.
Liked
1
0 replies
Hide branch
Load more comments...
Loading...
Wall post
Replies
B-
Birgit -Maria shared experience on Zentraler Stress Trauma Vagus Sympathikus
9 months ago
I am very satisfied, but often too impatient
Show original
0 Likes
0 Comments
Load more comments...
Loading...
Show modal
open modal
We use cookies to ensure you get the best experience on our site. Learn more
OK
Show modal